Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Allergy & Clinical Immunology

Reuters Health • The Doctor's Channel Daily Newscast

Infliximab plus azathioprine effective for stubborn Crohn’s disease

NEW YORK (Reuters Health) – In adults with moderate-to-severe active Crohn’s disease, treatment with infliximab plus azathioprine, or infliximab alone, led to significantly higher rates of corticosteroid-free clinical remission and mucosal...

Reuters Health • The Doctor's Channel Daily Newscast

Deadly fungal infections often occur late after organ transplantation

NEW YORK (Reuters Health) – Solid organ recipients often develop invasive fungal infections months or even years after transplant, according to registry data from the U.S. Depending on the organism, one-year mortality ranges up to 40%, investigators...

Reuters Health • The Doctor's Channel Daily Newscast

Long-term abatacept safe, usually effective for juvenile idiopathic arthritis

NEW YORK (Reuters Health) – Four out of five children with juvenile idiopathic arthritis had a good clinical response to abatacept during a long-term open-label extension trial. The safety profile was good, and the level of response often increased...